Kokoro (Aframomum melegueta)

Aframomum melegueta (grains of paradise) contains bioactive compounds including 6-paradol and flavonoids that may help regulate blood sugar by inhibiting α-amylase and α-glucosidase enzymes. The seed extract shows preliminary antioxidant properties through its rutin, epicatechin, and kaempferol content.

Category: African Evidence: 4/10 Tier: Preliminary (in-vitro/animal)
Kokoro (Aframomum melegueta) — Hermetica Encyclopedia

Origin & History

Aframomum melegueta, known as grains of paradise or kokoro, is a perennial herb in the ginger family native to West Africa, particularly Ghana, Nigeria, and Liberia, where its pungent seeds are harvested as the primary medicinal part. The seeds are processed through methanol Soxhlet extraction, hydro-distillation, or ethanol extraction to yield bioactive compounds including gingerols, shogaols, and paradols.

Historical & Cultural Context

In West African traditional medicine, particularly in Ghana and Nigeria, Aframomum melegueta seeds have been used for centuries as both a spice and remedy for inflammation, diabetes, infections, and digestive issues. Historical applications include anti-cancer, hepato-protective, and body fat-lowering effects in African herbal practices.

Health Benefits

• May help regulate blood sugar through α-amylase and α-glucosidase enzyme inhibition (preliminary in vitro evidence)
• Contains antioxidant flavonoids including rutin, epicatechin, and kaempferol (4.02-24.56 mg/100g) that may protect against oxidative damage (preliminary evidence)
• Shows potential anti-inflammatory activity via compounds like α-humulene and β-caryophyllene (computational studies only)
• May inhibit mTOR signaling pathway relevant to cancer therapy (computational analysis only)
• Traditional use for digestive issues supported by presence of phenolic compounds (traditional evidence only)

How It Works

Aframomum melegueta's primary bioactive compound 6-paradol inhibits carbohydrate-digesting enzymes α-amylase and α-glucosidase, potentially slowing glucose absorption. The flavonoid compounds rutin, epicatechin, and kaempferol provide antioxidant activity by scavenging free radicals and reducing oxidative stress markers. These mechanisms may contribute to improved glucose metabolism and cellular protection.

Scientific Research

Currently, no human clinical trials, RCTs, or meta-analyses have been conducted on Aframomum melegueta. Available evidence is limited to in vitro, computational modeling, and animal studies, with human validation still needed.

Clinical Summary

Current evidence for Aframomum melegueta is limited to preliminary in vitro studies examining enzyme inhibition and antioxidant capacity. Laboratory analyses have quantified flavonoid content at 4.02-24.56 mg/100g, with rutin being the predominant compound. No human clinical trials have been conducted to establish therapeutic efficacy, safety profiles, or optimal dosing regimens. The existing research represents early-stage investigation requiring substantial clinical validation.

Nutritional Profile

{"macronutrients": {"fiber": "approximately 8-10g/100g"}, "micronutrients": {"vitamins": {"vitamin C": "trace amounts"}, "minerals": {"potassium": "around 300mg/100g", "calcium": "approximately 20mg/100g", "magnesium": "approximately 40mg/100g"}}, "bioactive_compounds": {"flavonoids": {"rutin": "4.02-24.56 mg/100g", "epicatechin": "present", "kaempferol": "present"}, "terpenes": {"\u03b1-humulene": "present", "\u03b2-caryophyllene": "present"}}, "bioavailability_notes": "The bioavailability of flavonoids and terpenes may vary based on preparation and individual absorption factors."}

Preparation & Dosage

No clinically studied dosage ranges are available from human trials. Extracts are often standardized to 6-paradol (30.5%), 6-gingerol (19.5%), or 6-shogaol (12.5%) content, but specific therapeutic doses remain unestablished. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginger, Turmeric, Cinnamon, Black Pepper, Green Tea Extract

Safety & Interactions

Safety data for Aframomum melegueta supplementation is extremely limited due to lack of human studies. As a member of the ginger family, it may potentially interact with anticoagulant medications or affect blood sugar levels in diabetic patients. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data. Individuals with bleeding disorders or scheduled for surgery should exercise caution given potential effects on blood clotting.